Skip to content

Common Stock at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$236K+2.6%
ALN
Alnylam PharmaceuticalsALNY
250M0.0%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
200M0.0%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$1.44B+2.0%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
300M0.0%
Absci Corporation logo
Absci CorporationABSI
$15K+15.4%

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
Enterprise value$452.14M+302%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity-0.1×
Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assembly Biosciences's common stock?
Assembly Biosciences (ASMB) reported common stock of $16K in Q1 2026.
How has Assembly Biosciences's common stock changed year-over-year?
Assembly Biosciences's common stock increased by 100.0% year-over-year, from $8K to $16K.
What is the long-term trend for Assembly Biosciences's common stock?
Over 5 years (2020 to 2025), Assembly Biosciences's common stock has grown at a -14.0% compound annual growth rate (CAGR), from $34K to $16K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).